Title: Emergency Psychiatry (The Acutely Disturbed Patient)
1Emergency Psychiatry (The Acutely Disturbed
Patient)
- A/Professor David Ash
- Senior Visiting Consultant
- Intensive Care Unit
- Glenside Hospital
2Introduction
- 1. A/Professor David Ash
- Overview
- Setting
- Cedars Psychiatric Intensive Care Unit
- Violence and aggression
- Pharmacotherapy
- Agitated, psychotic patient
- Mania, schizomania
- Bipolar depression, schizodepression
- Unipolar depression
- Patient perspective
- ECT
- Substance abuse
3Overview
- Emergency psychiatry is a subspecialty of
psychiatry that has evolved over the last 30
years. - Reduction in inpatient beds has resulted in the
growth of psychiatric emergency services and an
increase in the numbers of people seen in the
community. - Principles of crisis intervention.
4Psychiatric Emergencies
- No single condition or illness
- Any situation requiring immediate assessment and
rapid intervention - Involve behavioural disturbance, threat of
behavioural disturbance, physiological
disturbance, high risk assessment
5Psychiatric Emergencies
- Suicidal Presentations
- Aggression and Violence
- Acute psychosis
- Mood disorders mania and depression
- Personality disorders in crisis
- Major disasters
6Psychiatric Emergencies
- Alcohol / substance abuse or intoxication
- Medical conditions
- Delirium
- Neuroleptic Malignant Syndrome
- Serotonin syndrome
- Lithium toxicity
7Psychiatric Emergencies
- Alcohol / substance abuse or intoxication
- Medical conditions
- Delirium
- Neuroleptic Malignant Syndrome
- Serotonin syndrome
- Lithium toxicity
8Risk Assessment
- Self harm
- Self neglect
- Victim of aggression, violence
- Suicide
- Disinhibition
- Impulsivity
- Restlessness, agitation
- Harassment, verbal aggression
- Threatened / actual aggression, violence
- Absconding risk
- Available support
- Insight
- Ability to work with treating clinicians
- Availability of suitable accommodation
- Substance use
- Alcohol
9The Setting
- Community
- Crisis units / short stay units/ crisis beds
- Emergency department
- Inpatient unit
- High dependency unit (HDU) / Intensive care unit
(ICU)
10The Community
- Location community clinic, patients home
- Preferred by patients
- Able to assess persons capacity to cope in
familiar home environment - Presence of family, neighbours, friends
- Safety issues
- Work in pairs
- Risk assessment prior to visit, if necessary
police in attendance - Weapons
- Ensure front door not deadlocked
- Decision to detain end interview ensure that
ambulance, police in attendance
11I didnt know they made house calls
12Emergency Department
- Triage
- Safe environment for emergency evaluation
- Weapon screening
- Rooms in which the examiner cannot be easily
trapped - Open vs enclosed interview area
- Method to call for help
- Adequate personnel to respond if help is needed
including trained security personnel
13Crisis Units / Short Stay Units/ Crisis Beds,
PECCU
- Location community, mental health centres,
psychiatric hospitals (Ash, Galletly), general
hospitals (Frank et al) - Short term crisis admission, triage, transfer
- Early discharge, community treatment
14Inpatient Units
- Higher acuity
- Aggression and violence
- Substance abuse
- Forensic issues
- Homelessness (Ash, Galletly et al)
15Inpatient Units
- Safe environment for patients / staff
- Time out, restraint, seclusion
- Guidelines for risk management
- Staff training / staff morale
- Leadership / support
- Linkage and communication with community
resources
16Not much of a psychiatric unit, though, is it?
17ICU / HDU
- Admission to the ICU / HDU is indicated for
- Dangerous, aggressive self harming behavior, not
able to be contained in a less restrictive
environment
- Aim for brief admission with
- Intensive treatment
- High nurse / patient ratios
- Calming environment
- Recovery based services
- Potential disadvantages of ICU / HDU
- Risk of assault
- Overmedication
- Overstimulation
- Worsening of symptoms
- PTSD
18- Options
- 1. Central, stand alone ICUs
- 2. Smaller HDU / ICUs in inpatient units
- Flexibility, closed / open options
- 3. Intensive nursing 11 in open ward
- Associated Issues
-
- consumer involvement
- how to reduce trauma associated with inpatient
care in the HDU / ICU - safety care plans
- sensory modulation
- debriefing, counselling following seclusion and
restraint
19Cedars PICU - Adelaide
- Intake from CNAHS (North, East), overflow
from West - Rural and Remote (on Glenside Campus) all
indigenous people - 10 beds
- Cedars PICU Psychiatrist 1.1 FTE
- Psychiatric Registrars 1 2 FTE
- CSC 1 FTE
- CN 1 FTE
- Primary Nurses 4
- Social Worker 1 FTE
- Drug and Alcohol Clinician 0.2 FTE
- Carer Support Worked 0.5 FTE
-
- Daily handover meetings and clinical review
- Experienced nursing staff
- Non-pharmacological interventions include
- One to one counselling and support
- Recovery-focussed care
- Early intervention/de-escalation techniques
- Psycho-education
- Drug and alcohol counselling
- Judicious use of medication, restraint, seclusion
20Cedars PICU - Adelaide
- Routine monitoring of electrolytes, renal
function, liver function, glucose, cholesterol,
lipid profile, ECG, BMI
21Treatment of Behavioural Emergencies summary of
expert consensus guidelines
- Preferred initial interventions for an imminently
violent patient - Verbal intervention
- Voluntary medication
- Show of force
- Emergency medication
- Offer food, beverage, other assistance
- Alternate Interventions
- Physical restraint
- Locked or unlocked quiet room, seclusion
22Treatment of Behavioural Emergencies - summary of
expert consensus guidelinesWhen to use physical
restraint
- Extremely or usually appropriate
- Acute danger to other patients, bystanders, staff
or self - Sometimes appropriate
- To prevent an involuntary patients from leaving
prior to assessment or transfer to a locked
facility - Rarely or never appropriate
- Lack of resources to supervise patient adequately
- To prevent a voluntary patient from leaving prior
to assessment - To maintain an orderly treatment environment
- History of previous self-injury or aggression
23(No Transcript)
24Illusion - self deception in regard to the memory
of a past experience
25Violence and Aggression
- Aggression Hostile or destructive behaviour or
actions - Violence Physical force exerted for the purpose
of violating, damaging, or abusing - Contemporary concerns
-
- Unprovoked, haphazard violence
- Violence by people suffering from mental illness
- Terrorism
26Models of Aggression
- Don Grant
- dehumanization
- acceptance of violence
- rage and its control
-
- Learning Theory
- Bandura - imitation and modeling of aggression
-
- Megargee
- over vs under controlled personality
-
- Group dynamics
- primitive, murderous rage
27Psychodynamic Concepts of Aggression
- aggression as an innate drive
- ambivalence of primary love object
- deficits in superego development
- defence against feelings of inferiority or
impotence - splitting
- displacement
- projection
- projective identification
28Social and Cultural Aspects
- Young men in low socioeconomic groups have an
increased risk of violence and of being a victim
of violence - USA nonwhites are more likely to be offenders
and victims of violence - There are differences between countries (e.g.
Europe compared to USA) - Culture
- Subcultures of violence
- Regional cultures of violence
- Societal values and violence
- Economic inequality and criminal violence
- Inequality of opportunity and criminal violence
29Biological
- Lorenz aggression is an inherent
tension-producing drive - Amygdala, hypothalamus, prefrontal cortex, limbic
system - Cortical dysfunction e.g. abnormal EEG in
antisocial personality disorder - Genetic e.g. sex chromosome abnormalities
- Hormonal
- Neurotransmitters
- ? GABA, ? serotonin, ? noradrenalin and ?
dopamine are associated with increased aggression - Alcohol, substance abuse
30Developmental Factors Associated with Adult
Violence
- Abuse by parents
- Truancy, school failure, lower IQ
- Delinquency as an adolescent
- Arrest for prior assaults
- Childhood hyperactivity
- First psychiatric hospitalization by age 18 years
- Fire setting and animal cruelty
- History of being a childhood bully
31Risk Factors for Aggression or Violence
- young, male
- developmental factors
- less education
- lack of sustained employment
- lower socioeconomic status
- history of substance abuse
- acute intoxication with alcohol and / or
psychoactive substances - past history of violence, aggression
- violent fantasies
- forensic history
32Risk Factors for Aggression and Violence
(continued)
- chronic anger towards others
- recent sense of being unfairly treated.
- residential instability homeless mentally ill
more likely to offend - antisocial / borderline personality disorder
- mania
- acute psychosis delusional beliefs involving
particular individuals - command hallucinations
- delirium
- dementia
33Paranoia delusions of persecution
34Assessing the Aggressive, Violent Patient
- Aims
- To ensure your own safety
- To ensure the safety of staff and other patients
- To keep the patient safe
- To detect the presence of acute medical problems
- To detect the presence of psychiatric illness
- To achieve rapid stabilization and disposition of
the patient
35Clinical Evaluation
- Remain at a safe distance
- Privacy but not isolation
- Offer food, drink, universal language of
hospitality - Look and listen, be respectful
- Talk with an even, concerned tone of voice
- Consider the timing of questions and directions
- Ask simple questions
- Avoid being provocative
- Agree to disagree
- Maintain observational awareness warning signs
- Obtain collateral history
36Clinical Evaluation
- The environment should not be fragile
- Know where the alarms are located and how to
activate them - Ensure availability, presence of adequately
trained staff and security personnel - Ensure a means of escape
37Predictors of Impending Violence Include
- Refusal to cooperate
- Intense staring
- Motor restlessness
- Purposeless movements
- Labile affect
- Loud speech
- Irritability
- Intimidating behavior
- Damage to property
- Demeaning or hostile verbal behavior
- Direct threat of assault
Hillard and Zatek
38Management
- Establish differential diagnosis
- Attempt where possible to initiate treatment with
medication to treat underlying illness. - Assess risk to others (specific threats) duty
to warn - Weapons firearms notification
- Where to treat?
- Voluntary or detained?
- Use verbal strategies initially if necessary use
- restraint, emergency medication, seclusion
- Liaise with treating team/clinicians (if any)
- If no evidence of psychiatric or medical illness
- consider involving the police.
39Pharmacotherapy General Principles
- Choice of medication is based on
-
- diagnostic assessment,
- past history,
- medical comorbidities,
- substance abuse and intoxication
40Choice of Medication
- Consider
- speed of onset
- oral vs IM
- duration of action
- side effects
- past response
- patient preference
41Consumer Perspective
- Consumers stress the importance of staff treating
them with respect, communicating, listening,
involving them in treatment decisions (Allen) - Expert Consensus Guidelines (Behavioral
Emergencies), (Allen) - - Verbal interaction
- - Collaborative approach
- - Oral medication if possible guided by
consumers problems, medication experiences and
preferences -
- IM medication can be a symbolic assault
involving - Physical trauma
- emotional trauma
- Risk of side effects
- Compromises the clinician patient
relationship - May reduce future medication adherence
42Consumer Perspective
- 1/5 of a consumer panel attributed their
emergency contact to lack of access to more
routine mental health care - almost 50 of consumers said they wanted
medication and benefited from medication - Many complained about forced administration and
unwanted side effects
43Consumer Panel Stressed the Importance of
- Alternatives to traditional emergency room
services - Increased use of advance directives
- More comfortable physical environments
- Improved training of emergency unit staff to
foster a humane, person-centres approach - Collaboration between practitioners and consumers
- Improved discharge planning and reliable ,
consistent aftercare
44Benzodiazepines
Exercise caution in the use of benzodiazepines
- elderly
- patients with respiratory disease
- acute intoxication with alcohol
- severe impairment of hepatic or renal function
- depressed level of consciousness,
- patients using other sedating medications
45Midazolam
- Midazolam 2 10 mg (IM/IV) is often used in the
emergency department for agitated, aggressive
patients - Midazolam IM is also used in ICU Brentwood
- Risk of respiratory depression requires close
monitoring and ideally pulse oximetry - Onset of action 1 15 minutes (depending on
route of administration) - Half life 1 2.8 hours
46Clonazepam
- Clonazepam (0.5 2 mg) is a longer acting IM
alternative to midazolam but risks associated
with excessive sedation, ataxia - Onset of action 5 15 minutes
- Peak plasma levels in less than 4 hours
- Half life 20 40 hours
47Lorazepam
- Lorazepam (0.5 2.5 mg) is often favoured over
diazepam because of the shorter half life - Onset of action 5 15 minutes
- Peak plasma levels in 2 hours (oral and IM have a
similar absorption profile) - Half life 10 20 hours
- Less respiratory depression than Diazepam and
Midazolam
48Diazepam
- Diazepam (2.5 10 mg) is well absorbed orally
- IM absorption is erratic
- Onset of action (oral) up to 30 minutes
- Half life 14 - 60 hours (has multiple active
metabolites)
49Antipsychotic Medication
First Generation Antipsychotics Low Potency
? sedation postural hypotension ? EPS
- Chlorpromazine (oral)
- Onset of action up to 20 minutes with oral
medication - Peak plasma levels -2-4 hours
- Half life 24 hours (range 8-35 hours)
Intermediate Potency e.g. perphenazine
50First Generation Antipsychotics High Potency
tranquilization ? EPS
- Haloperidol (oral / IM)
- Time of Onset of action depends on route of
administration - IV immediate
- Oral - up to 60 minutes
- Half life 24 hours
51Zuclopenthixol
- Zuclopenthixol HCl (Clopixol) 10, 25mg tablets
- Onset of action 10-30 minutes
- Peak plasma levels in less than 4 hours
- Half life 24 hours
52Droperidol
- Droperidol is a high potency Butyrophenone
- Parenteral preparation
- Maximum dose 30 mg over 24 hours
- Onset action (IM) 1 20 minutes
- Duration of action 2 4 hours
- Half life 2.2 hours
- Prolongation QT interval
53Acuphase (Zuclopenthixol acetate)
- Acuphase (Zuclopenthixol acetate) short acting
depot used when IM medication is required, with
tranquilization lasting 24 to 72 hours - Onset of action 4 to 6 hours
- Monitor for EPS
- Exercise caution in treatment naive patients
54Second Generation Antipsychotics (SGAs)
- Risperidone (tablets, quicklets, depot)
- Paliperidone (tablets, depot)
- Olanzapine (tablets, wafers, short-acting IM,
depot) - Amisulpride (tablets, syrup)
- Aripiprazole (tablets, short-acting IM)
- Quetiapine IR, XR (tablets)
- Ziprasidone (tablets, short-acting IM)
- Clozapine (tablets, syrup)
55Second Generation Antipsychotics
- Until recently research suggested SGAs have
superior efficacy for negative symptoms,
cognition and mood in schizophrenia. - First episode psychosis (low dose)
- SGAs are also used
- For tranquilization and to reduce hostility in
agitated patients - In mania and depression
- As mood stabilizers
- In anxiety disorders including GAD and social
anxiety disorder - As augmentation treatments in OCD and
treatment-resistant depression - As monotherapy / augmentation in PTSD and
borderline personality disorder - Behavioral disturbance in dementia and brain
injury
56Second Generation Antipsychotics
- Less likely to cause EPS, although can occur with
2nd generation antipsychotics esp. Risperidone,
Amisulpride in higher doses (Aripiprazole
restlessness) - EPS less likely with Quetiapine and Clozapine
- Metabolic syndrome (predominantly Clozapine,
Olanzapine) - Cardiovascular / cerebrovascular events in the
elderly ?class effect - Postural hypotension (Risperidone, Quetiapine)
- Hyperprolactinemia (Risperidone, Amisulpride)
- QTc prolongation (e.g. Ziprasidone, Amisulpride,
Quetiapine)
57Second Generation Antipsychotics Controversies,
Unresolved Issues
- Drug development studies have focused on
reduction in symptoms severity with restrictive
inclusion / exclusion criteria. - Short term, narrowly focused trials provide
limited information about the effectiveness of
drugs in clinical practice. - Recent studies have raised questions about the
advantages of SGAs in schizophrenia (CATIE,
CAFÉ, CUtLASS 1, EUFEST, Goldberg et al)
58Risperidone
- Oral, quicklets
- 0.5 2 mg stat dose
- Onset action 10 - 30 minutes
- Peak plasma levels 1-2 hours
- Duration of action 6 - 10 hours
- Half life 19 hours
- Postural hypotension, EPS (high dose),
hyperprolactinemia
59Paliperidone
- Active metabolite of risperidone
- Prolonged release tablet
- Peak plasma concentrations about 24 hours after
oral dosing - Elimination half-life of about 23 hours
- Similar side effects to risperidone
60Olanzapine
- Oral, wafers, IM
- 2.5 10 mg stat dose
- Onset of action 15 - 60 minutes
- Peak plasma levels 15 minutes -8 hours (depending
on route of administration) - Half life 27 hours
- Metabolic syndrome, sedation
61Amisulpride
- Oral tablets, syrup
- Peak plasma level 1 4 hours
- Half life 12 hours
- EPS, hyperprolactinemia and QTc prologation at
high dose
Aripiprazole
- Oral tablets
- Onset action 1 3 hours
- Peak plasma level 3-5 hours
- Half life 75 hours
- Restlessness
62Quetiapine IR
- Oral - tablets
- 50-150mg stat dose
- Onset of action 10 - 30 minutes
- Peak plasma level 1-5 hours
- Duration of Action 4 - 12 hours
- Half life 6-7 hours
- Postural hypotnesion,sedation
- ? QTc prologation at high dose
- XR form now available, longer half life.
63Ziprasidone
- 80 160 mg / day
- Must be taken with food
- Low incidence weight gain
- Akathisia
- QTc prologation
64Clozapine
- Oral - tablets
- Peak plasma levels 2-5 hours
- Half life 12 hours
- Agranulocytosis, myocarditis, cardiomyopathy,
metabolic syndrome, lower seizure threshold
balance benefit against risk.
65Antipsychotics and Risk of Sudden DeathStraus et
al. 2004
- Precise mechanism uncertain, suggestions include
- Peripheral vasodilatation and cardiovascular
collapse - Oral laryngeal / pharyngeal dystonia
- Acute myocarditis
- Cardiomyopathy
- QTc prolongation
66Antipsychotics and Risk of Sudden Death Straus
et al. 2004
- Integrated Primary Care Information Project
- 554 cases of sudden cardiac death
- Current use of antipsychotics was associated with
a 3 fold increase in the risk of sudden cardiac
death - Risk highest with butyrophenone antipsychotics
(e.g. haloperidol / droperidol) and short term use
67QTc Interval
- Dose dependant prolongation of QTc interval may
potentiate risk of serious ventricular
arrhythmias such as Torsade de Pointes (rare
occurrence lt 0.01) - Risk enhanced by existence of
- bradycardia (lt 55)
- hypokalaemia
- congenital prolongation of QTc interval
- treatment with medications that produce
pronounced bradycardia, slowing of intracardiac
conduction or prolongation of QTc interval - should not be given with drugs that induce
arrythmias such as amiodorone, quinidine,
sotolol, cisapride, thioridazine and erythromycin
68Medication for agitated, psychotic patients
Generally involves a combination of
- Oral atypical antipsychotic
- Oral benzodiazepine in the first instance
If compliance is an issue
- Olanzapine / risperidone dissolvable wafers or
- Risperidone / amisulpride syrup
69Parenteral Medication
- If patient more agitated or unwilling to accept
oral medication - IM olanzapine or IM haloperidol plus
- IM lorazepam / clonazepam /midazolam
- If patient extremely agitated and presents an
ongoing threat to self or others or has not
responded to IM olanzapine / IM haloperidol
consider use of - zuclopenthixol acetate plus
- IM lorazepam / clonazepam / midazolam
- Monitor level of sedation, respiration. Ideally
pulse oximetry if using midazolam.
70Mania / Schizoaffective Disorder with Mania
Medications which have efficacy include
- Quetiapine
- Risperidone
- Aripiprazole
- Clozapine
- Lithium Carbonate
- Sodium Valproate
- Carbamazepine
- Olanzapine
- ziprasidone
In practise second generation antipsychotics are
often used in combination with anticonvulsants /
lithium carbonate. Concurrent use of oral /
parenteral benzodiazepines to sedate and reduce
arousal.
71Sodium Valproate
- loading dose 20-30 mg/kg.
- If no response after 7 - 10 days consider
alternative mood stabilizer - more efficacious in patients with
- mixed affective states
- rapid cycling
- comorbid substance abuse
72Bipolar Depression / Schizoaffective Disorder
with Depression
- Optimize mood stabilizer
- Antidepressant medication ? Efficacy in BP
depression - Benzodiazepines to reduce arousal / agitation
- SGA to reduce arousal / agitation and/or
psychotic symptoms, augment treatment of
depression - If compliance has not been an issue consider an
alternative mood stabilizer - Lamotrigine has efficacy in prophylaxis of
bipolar depression however has limited value in
the acute setting - Monitor mood / suicidal ideation provision of
treatment in safe environment - SGA monotherapy in bipolar depression
73Unipolar Depression
- Antidepressant medication
- Second generation antipsychotic monotherapy
(quetiapine) - Second generation antipsychotic to reduce arousal
/ agitation and / or psychotic symptoms - Benzodiazepines to reduce arousal / agitation
- Monitor mood / suicidal ideation provision of
treatment in safe environment - Consider augmentation strategies e.g. lithium,
thyroxine, second generation antipsychotic etc.
74Schizophrenia
- RANZCP Clinical Practice Guidelines, McGorry et
al 2005 - SGA treatment of first choice
- Conventional antipsychotic in low dosage where
there is remission, good tolerability, or depot
medication unavoidable - Consider clozapine if there is incomplete
remission with at least 2 other antipsychotic
agents - Psychosocial interventions assertive community
treatment, medication adherence therapy,
(cognitive remediation therapy) - Consumer involvement
- Physical health prevention and early treatment
of medical illness - Shared care with GP.
75Treatment Resistant Schizophrenia
- Also
- Clozapine / amisulpride combination
- Clozapine / aripiprazole combination
- Clozapine / ECT
76ECT - Indications
- Depression
- Bipolar depression
- Unipolar depression
- Psychotic features
- Lack of response to pharmacotherapy
- Severe illness with significant risk to self
through suicide or self neglect - Mania
- Severe mania unresponsive to pharmacotherapy
77ECT - Indications
- Schizophrenia
- Catatonia
- Associated depression
- Inadequate response to pharmacotherapy
- Severe illness, risk to self, others
- Evidence for combined clozapine and ECT in
treatment refractory schizophrenia
78Shock treatment therapy used to alter favorably
the course of a mental illness
79Substance Abuse
- Two to three times more common among those with
psychiatric illness than in general population. - Negative attitudes towards this subset of the
population hinders the provision of effective
care. - Urine drug screening helpful
80Common Substances of Abuse
- Alcohol
- Cocaine
- Amphetamine
- Methamphetamine
- MDMA (3,4 methylene dioxymethamphetamine),
(ecstasy) - Ketamine
- Cannabis
- Opiates
81The Drug Abusing Patient
- Patient may present with intoxication or
withdrawal symptom. - Stimulant intoxication may induce paranoid
symptoms, delirium. - Opiate withdrawal marked by pupillary dilatation,
lacrimation, diarrhoea, cramping - Patient may present with physical symptoms and
demand opiates for pain relief
82Amphetamine Methamphetamine Abuse
- Clinical Presentation
- Acute anxiety
- Paranoid ideation
- Loud, demanding behaviour
- Motor agitation, aggression
- Stereotypic behaviours sniffing, teeth
clenching, purposeless searching, picking of skin - May be evidence of needle marks
- Pulse, BP, respiration rate, increased and
dilated pupils - Exacerbation, precipitation of mania/psychosis
- Persisting delusional state
83Treatment
- Support, verbal de-escalation
- Safety first potential for aggression
- Benzodiazepines to reduce arousal
- Second generation antipsychotics
- i.e. Olanzapine - Quetiapine
- Monitor for orthostatic hypertension with SGAs
- ECG QTc
- General medical including hydration, malnutrition
- Routine screens including Biochemistry, CBP, Hep
screens, HIV - Assess need for inpatient treatment
- Referral to specialist drug, alcohol service
where appropriate
84Case Presentation
- Mrs B. 52 year old married woman, lives in a
country town 200km from Adelaide. 2 sons aged 28,
33 years. - sexual assault by chiropractor, later
developed severe illness with mood disturbance,
auditory and ?olfactory hallucinations, passivity
experiences, religious delusions, delusions of
reference. - Past History postpartum depression social
anxiety disorder - No family history of psychiatric illness
- Emotional deprivation, physical aggression and
neglect by parents esp. father. - History of sexual assaults in childhood,
adolescence and adult life - Husband emotionally abusive, controlling,
similarities to father
85Case Presentation cont.
- Employed as registered nurse, managed several
successful businesses prior to illness onset. - Self esteem linked to work, parenting, physical
appearance. - Since 1995 chronic, fluctuating psychotic
symptoms with episodic mood disturbance. Ongoing
social anxiety and posttraumatic symptoms. - Underlying Axis 2 issues although functioned well
prior to illness onset. - Organic screens including EEG, CT head, MRI head,
ECG, echocardiogram NAD.
86Case Presentation cont.
- Intensive outpatient treatment including
- Supportive psychotherapy
- Psychoeducation
- Marital counselling
- Theological input
- CBT
- Cautious exploration of past traumas and
underlying dynamic issues - Pharmacotherapy
- Second and third opinions
- Inpatient treatment
- numerous admissions including ICU due to
psychotic symptoms and risk of self harm - Traumatic experience in hospital
87Case Presentation cont.
- Pharmacotherapy
- FGAs oral / depot
- SGAs including clozapine
- Mood stabilisers
- Antidepressants
- Current medication
- Amisulpride 1,000 mg daily
- Seroquel 300 mg bd
- Benztropine 2-3 mg daily
- Lorazepam 1.5 mg daily
- Temapzepam 10 mg prn nocte
- Psychotic symptoms have settled, mood stable for
last 6 months. - Still has moderately severe social anxiety.
88(No Transcript)
89References
- Crisis Beds The Interface Between the Hospital
and the Community. Ash et al. International
Journal of Social Psychiatry 43 193 -198, 1997 - Development of Australias first psychiatric
emergency centre. Frank et al Australasian
Psychiatry, 13 266 - 272, 2005 - A survey of violence, self harm, victimisation
and homelessness in patients admitted to an acute
regional inpatient unit in South Australia. Ash
et al. International Journal of Social Psychiatry
49 112-118, 2003 - Self reported forensic histories amongst patients
admitted to an acute psychiatric unit. Ash et al.
Psychiatry, Psychology and the Law 6197-202,
1999 - Emergency Psychiatry ed Hillard and Zitek McGraw
and Hill - Psychotropic Drug Directory ed Basire 2003/2004
- Acute Inpatient Psychiatric Care A Source Book
Treatment Protocol Project WHO Andrews - Safety and Tolerability of Oral Loading
Divalproex Sodium in Acutely Manic Bipolar
Patients Hirschfeld et al, J Clin Psychiatry
1999 60, 815-818 - Managing the Agitated Psychotic Patient an
Update. Forster, Emergency Psychiatry 8 2, 2002
90- Efficacy of Atypical Antipsychotics in Bipolar
Disorder Berk and Dodd Drugs 2005 65 (2) 257-269 - Review and Update of the American Psychiatric
Association Practice Guidelines for Bipolar
Disorder James C-Y. Chou, Primary Psychiatry
Sept. 2004 11 (9), 73-84 - Treatment options for Bipolar Mania Kasper and
Attarbaschi, Clinical Approaches in Bipolar
Disorders 2004 3. 24-32 - RANZCP Clinical Practice Guidelines Summary of
guidelines for the treatment of bipolar disorder
P Mitchell et al, Australasian Psychiatry, Vol
11, No.1, March 2003 - A Meta-analysis of the Efficacy of Second
Generation Antipsychotics John Davis, Nancy Chen,
Ina Glick. Arch. Gen. Psychiatry Vol 60 June
2003, 553-564 - RANZCP Clinical Practice Guidelines Summary of
Guidelines for the treatment of Schizophrenia
McGorry et al Australasian Psychiatry Vol 11 No
2, June 2003, 135-150 - What Do Consumers Say They Want and Need During a
Psychiatric Emergency Allen et al, J Psychiatr
Pract. 2003 9 (1), 39-58 - Treatment of Behavioural Emergencies a summary
of the expert consensus guidelines Allen et al ,
J Psychiatr Pract. 2003 9 (1), 16-38 - Goldberg et al Cognitive improvement after
treatment with second-generation antipsychotic
medications in first-episode schizophrenia is it
a practice effect? Arch Gen Psychiatry 2007 64
1115-22
91- Atypical antipsychotics in the treatment of
schizophrenia systematic overview and
metaregression analysis Geddes et al 2000, BMJ
321, 1371-1376 - The European First Episode Schizophrenia Trial
(EUFEST) Rationale and design of the trial.
Fleischhacker et al 2005 Schizophrenia Research
78, 147-156 - Antipsychotics and the Risk of Sudden Cardiac
Death. Straus et al, Arch Int Med 2004 164
1293-1297. - The Usefulness and Use of Second Generation
Antipsychotic Medication Sartorius et al 2002
Current Opinion in Psychiatry 15, S1-S51 - The Usefulness and Use of Second Generation
Antipsychotic Medication Sartorius et al 2003
Current Opinion in Psychiatry 16, S44 - Guidance on New (Atypical) Antipsychotic Drugs
for the Treatment of Schizophrenia National
Institute of Clinical Excellence (NICE) Barnett
2002 - Effectiveness of Antipsychotic Drugs in Patients
With Chronic Schizophrenia Lieberman et al New
England Journal of Medicine 2005 353 12
1209-1223 - Clinical Trials for Antipsychotic Drugs design
conventions, dilemmas and innovations. Stroup et
al, Nature Reviews Drug Discovery 2006 5, 133-146 - Randomised Controlled Trial of the Effect on
Quality of Life of Second vs First-Generation
Antipsychotic Drugs in Schizophrenia, CUtLASS 1,
Arch Gen Psychiatry, Vol 63, Oct 2006.
92- Treatment of a first episode of psychotic illness
with quetiapine. An analysis of 2 year outcomes.
Kopola et al. Schizophrenia Research 81 (2006)
29-39. - Higher than Physicians Desk Reference (US) doses
on atypical antipsychotics, Goodnick, Expert
Opinion Drug Saf. (2005) 44) 653-668 - Clinical experience with atypical antipsychotics
in an acute inpatient unit. Focus on quetiapine.
Keks et al., International Journal of Psychiatry
in Clinical Practice, 2006 10(2) 0-00. - RANZCP Clinical Practice Guidelines Summary of
guidelines for the treatment of bipolar disorder
Mitchell et al, Australasian Psychiatry, Vol 11,
No.1, March 2003 - Amisulpride augmentation of Clozapine an open
non-randomized study in patients with
schizophrenia partially responsive to Clozapine
Munro et al, Acta Psychiatrica Scand. 2004 110,
292-298 - Co-administration of Clozapine and Amisulpride in
patients with Schizophrenia. Ziegenbein et al
58th Annual Convention Biol. Psychiatry May 2003
- Combination of Clozapine and Amisulpride in
Treatment Resistant Schizophrenia case reports
and review of the literature Zink et al,
Pharmacopsychiatry 2004 27, 20-31 - Differential effects of high-dose amisulpride
versus flupenthixol on latent dimensions of
depressive and negative symptomatology in acute
schizophrenia an evaluation using confirmatory
factor analysis Muller et al., Int. Clin.
Psychopharmacol 2002 Sep, 17 (5) 249-61